Clinical Outcomes Assessment Development

Oracle is a global leader for clinical outcomes assessments (COAs), including patient-reported outcomes (PRO) and observer-reported outcomes (ObsRO) instruments. We can help you to capture your patients’ perspectives with unmatched precision.

Clinical outcomes assessment development solutions

Designing and validating your patient-reported outcomes (PRO)

Oracle Life Sciences can design and validate your patient-reported outcomes (PRO) and observer-reported outcomes (ObsRO) instruments to precisely measure health outcomes or aspects of quality of life from patients’ and caregivers’ perspectives. In our development phase, we can craft the instrument to accurately capture patient experiences and symptoms using concept elicitation and item generation. Our scale validation, which includes cognitive debriefing interviews and psychometric validation, then verifies the instrument’s relevance, reliability, and accuracy. Harness the resulting PRO instruments in your clinical trial planning, drug design, regulatory decisions, and real-world evidence generation.

Insight across diverse cultures and borders

If your PRO/ObsRO tool will be used internationally or among different cultural groups, any translations must maintain the instrument's original meaning and intent. We provide rigorous linguistic and cultural adaptation support to meet this need.

An experienced team with a proven track record

The Oracle Life Sciences team is composed of outcomes researchers, methodologists, and statisticians who bring extensive experience in new measure development and measure utilization across numerous therapeutic areas. The team’s market- and disease-specific expertise can be observed in more than 2,000 scientific publications, including articles, posters and abstracts.

The depth of Oracle expertise in patient-reported outcomes is also reflected in the Oracle Life Sciences National Health and Wellness Survey (NHWS), the largest database of projectable, self-reported patient outcomes and health information. The NHWS includes 35 validated scales and disease-specific assessment measures, providing rigorous patient-reported data on outcomes, attitudes, behaviors, characteristics, and demographics, with national projections on more than 200 conditions in 12 countries.

从 Oracle 生命科学开始


订阅博客

了解最新观点和优秀实践,助力临床成功。


获取技术支持

了解技术支持团队联系方式和资源。


关注我们的播客

了解思想领袖关于生命科学行业趋势的真知灼见。


联系我们

联系我们,了解关于临床研究和药物警戒的更多信息。

注:为免疑义,本网页所用以下术语专指以下含义:

  1. Oracle专指Oracle境外公司而非甲骨文中国。
  2. 相关Cloud或云术语均指代Oracle境外公司提供的云技术或其解决方案。